Plain-English translation of NCT06585462 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called to see if it is safe and how the body responds to it. The trial will give some participants the actual medication and others a placebo (inactive injection) so researchers can compare results fairly. This is one of the first times this medication is being tested in humans.
Obesity and related health conditions affect millions of people, and current treatment options are limited. Researchers are developing this medication as a potential new tool to help people manage their weight and improve cardiometabolic health.
You likely qualify if…
You likely don't qualify if…
The trial has two parts. In Part A, you would receive one dose of the medication (or placebo) as an injection under the skin or into a vein, then be monitored for safety. In Part B, you would receive multiple doses of the medication (or placebo) over time as injections under the skin. Throughout the trial, you would have blood tests, physical exams, and follow-up visits so researchers can track how your body responds and watch for any side effects.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States